The Landscape of Emerging Randomized Clinical Trial Evidence for COVID-19 Disease Stages: A Systematic Review of Global Trial Registries

Alison Dillman1 School of Public Health, Faculty of Medicine, Imperial College London, London, England

Michael J Zoratti2 Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada

Jay J H Park3 Department of Experimental Medicine, University of British Columbia, Vancouver, British Columbia, CanadaCorrespondence[email protected]

Grace Hsu2 Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada

Louis Dron2 Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada

Gerald Smith2 Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada

Ofir Harari2 Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada

Craig R Rayner4 Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia

Noor-E Zannat2 Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada

Alind Gupta2 Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada

Eric Mackay5 Department of Statistical Sciences, University of Toronto, Toronto, Canada

Paul Arora6 Dalla Lana School of Public Health, University of Toronto, Toronto, Canada

Zelyn Lee7 Department of Physiology & Department of Neuroscience, University of Toronto, Toronto, Canada

Edward J Mills2 Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada

Articles from other publishers (8)